GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era
VANCOUVER, British Columbia, Dec. 12, 2025 (GLOBE NEWSWIRE) — Equity-Insider.com News Commentary – The FDA approved the first perioperative immunotherapy for early gastric and gastroesophageal junction cancers last month, ushering in a new clinical …